Our results showed that KA supplementation to be beneficial to muscle atrophy in CKD + LPD, which might be associated with improvement of oxidative damage and mitochondrial dysfunction through suppression of p66Shc and FoxO3a. The gene discussed is FOXO3; the disease is disseminated peritoneal leiomyomatosis.